2005
DOI: 10.1016/j.ijcard.2004.02.006
|View full text |Cite
|
Sign up to set email alerts
|

Electrocardiographic events and cholesterol reduction with pravastatin in patients with hypercholesterolemia: the Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…According to our findings, plasma lipids and smoking habit were not associated with a higher risk score. As for lipids, most of the subjects with hypercholesterolemia were treated with statins, which could reduce the incidence of ischemic ECG changes regardless of lipid concentrations, as shown in previous studies [11]. Furthermore, LDL-C mainly predicts ECG signs of previous myocardial infarction [12], which is just one of the five ECG alterations included in the Finnish Score.…”
Section: Discussionmentioning
confidence: 79%
“…According to our findings, plasma lipids and smoking habit were not associated with a higher risk score. As for lipids, most of the subjects with hypercholesterolemia were treated with statins, which could reduce the incidence of ischemic ECG changes regardless of lipid concentrations, as shown in previous studies [11]. Furthermore, LDL-C mainly predicts ECG signs of previous myocardial infarction [12], which is just one of the five ECG alterations included in the Finnish Score.…”
Section: Discussionmentioning
confidence: 79%